News

Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC
EMA Orphan Drug Designation (ODD) builds on U.S. Food & Drug Administration (FDA) ODD and Fast Track Designation, ...
Consilium1d
The pharma package: new EU rules on medicines
The purpose of the pharma package is to revise the current rules on medicines to make them more accessible to patients while ...
Medical Dialogues7h
Roche Evrysdi tablet gets European Commission approval for Spinal Muscular Atrophy
Basel: Roche has announced that the European Commission (EC) has approved a label extension for Evrysdi (risdiplam) to ...
Pharmabiz12h
European Commission approves Roche’s Evrysdi tablet to treat spinal muscular atrophy
European Commission approves Roche’s Evrysdi tablet to treat spinal muscular atrophy: Basel Thursday, June 5, 2025, 09:00 Hrs [IST] Roche announced that the European Commission ...
Medscape12d
Blenrep Gets European Nod to Treat Multiple Myeloma
Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...